These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 30244038)

  • 41. Activity of Ceftolozane-Tazobactam against Carbapenem-Resistant, Non-Carbapenemase-Producing Pseudomonas aeruginosa and Associated Resistance Mechanisms.
    Wi YM; Greenwood-Quaintance KE; Schuetz AN; Ko KS; Peck KR; Song JH; Patel R
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29133568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metallo-beta-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones.
    Juan C; Zamorano L; Mena A; Albertí S; Pérez JL; Oliver A
    J Antimicrob Chemother; 2010 Mar; 65(3):474-8. PubMed ID: 20071364
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Whole-genome sequencing, multilocus sequence typing, and resistance mechanism of the carbapenem-resistant Pseudomonas aeruginosa in China.
    Zhao X; Qin J; Chen G; Yang C; Wei J; Li W; Jia W
    Microb Pathog; 2024 Jul; 192():106720. PubMed ID: 38815778
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genotypes, carbapenemase carriage, integron diversity and oprD alterations among carbapenem-resistant Pseudomonas aeruginosa from Russia.
    Bocharova Y; Savinova T; Lazareva A; Polikarpova S; Gordinskaya N; Mayanskiy N; Chebotar I
    Int J Antimicrob Agents; 2020 Apr; 55(4):105899. PubMed ID: 31931151
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Draft genome sequence of KPC-2-producing Pseudomonas aeruginosa recovered from a bloodstream infection sample in Brazil.
    de Oliveira Santos IC; Albano RM; Asensi MD; D'Alincourt Carvalho-Assef AP
    J Glob Antimicrob Resist; 2018 Dec; 15():99-100. PubMed ID: 30172833
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SPM-1-producing Pseudomonas aeruginosa: analysis of the ancestor relationship using multilocus sequence typing, pulsed-field gel electrophoresis, and automated ribotyping.
    Silva FM; Carmo MS; Silbert S; Gales AC
    Microb Drug Resist; 2011 Jun; 17(2):215-20. PubMed ID: 21332364
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interplay between mutational and horizontally acquired resistance mechanisms and its association with carbapenem resistance amongst extensively drug-resistant Pseudomonas aeruginosa (XDR-PA).
    Shu JC; Chia JH; Siu LK; Kuo AJ; Huang SH; Su LH; Wu TL
    Int J Antimicrob Agents; 2012 Mar; 39(3):217-22. PubMed ID: 22079532
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Coexistence of multidrug resistance mechanisms and virulence genes in carbapenem-resistant Pseudomonas aeruginosa strains from a tertiary care hospital in South India.
    Ellappan K; Belgode Narasimha H; Kumar S
    J Glob Antimicrob Resist; 2018 Mar; 12():37-43. PubMed ID: 28893647
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of plasmid OXA and other β-lactamase genes among carbapenem-resistant isolates of Pseudomonas aeruginosa from the Clinical University Hospital in northeastern Poland.
    Sacha P; Michalska A; Ojdana D; Wieczorek P; Hauschild T; Majewski P; Tryniszewska E
    New Microbiol; 2015 Apr; 38(2):271-5. PubMed ID: 25938753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular analysis of carbapenem-resistant strains of Pseudomonas aeruginosa isolated from patients hospitalized in various transplantation wards between 2008 and 2011.
    Kosykowska E; Szymanek-Majchrzak K; Walter de Walthoffen S; Izdebski R; Mlynarczyk A; Ciszek M; Chmura A; Durlik M; Paczek L; Deborska-Materkowska D; Sawicka-Grzelak A; Mlynarczyk G
    Transplant Proc; 2014 Oct; 46(8):2576-8. PubMed ID: 25380869
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Carbapenem-resistant and cephalosporin-susceptible: a worrisome phenotype among Pseudomonas aeruginosa clinical isolates in Brazil.
    Campana EH; Xavier DE; Petrolini FV; Cordeiro-Moura JR; Araujo MR; Gales AC
    Braz J Infect Dis; 2017; 21(1):57-62. PubMed ID: 27916604
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Full characterization of the integrative and conjugative element carrying the metallo-β-lactamase bla SPM-1 and bicyclomycin bcr1 resistance genes found in the pandemic Pseudomonas aeruginosa clone SP/ST277.
    Fonseca EL; Marin MA; Encinas F; Vicente AC
    J Antimicrob Chemother; 2015 Sep; 70(9):2547-50. PubMed ID: 26093374
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital.
    Hammami S; Ghozzi R; Burghoffer B; Arlet G; Redjeb S
    Pathol Biol (Paris); 2009; 57(7-8):530-5. PubMed ID: 18977099
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Carbapenem resistance in Pseudomonas aeruginosa isolates: an example of interaction between different mechanisms].
    Santella G; Pollini S; Docquier JD; Almuzara M; Gutkind G; Rossolini GM; Radice M
    Rev Panam Salud Publica; 2011 Dec; 30(6):545-8. PubMed ID: 22358400
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of carbapenem-resistant Pseudomonas aeruginosa in selected hospitals of the Gulf Cooperation Council States: dominance of high-risk clones in the region.
    Zowawi HM; Syrmis MW; Kidd TJ; Balkhy HH; Walsh TR; Al Johani SM; Al Jindan RY; Alfaresi M; Ibrahim E; Al-Jardani A; Al Salman J; Dashti AA; Sidjabat HE; Baz O; Trembizki E; Whiley DM; Paterson DL
    J Med Microbiol; 2018 Jun; 67(6):846-853. PubMed ID: 29664716
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Determination of carbapenem resistance mechanism in clinical isolates of Pseudomonas aeruginosa isolated from burn patients, in Tehran, Iran.
    Mirsalehian A; Kalantar-Neyestanaki D; Taherikalani M; Jabalameli F; Emaneini M
    J Epidemiol Glob Health; 2017 Sep; 7(3):155-159. PubMed ID: 28756823
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Emergence of Carbapenem-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Clinical Isolates Collected from Some Libyan Hospitals.
    Mathlouthi N; Areig Z; Al Bayssari C; Bakour S; Ali El Salabi A; Ben Gwierif S; Zorgani AA; Ben Slama K; Chouchani C; Rolain JM
    Microb Drug Resist; 2015 Jun; 21(3):335-41. PubMed ID: 25587875
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hospital outbreak of multiple clones of Pseudomonas aeruginosa carrying the unrelated metallo-beta-lactamase gene variants blaVIM-2 and blaVIM-4.
    Pournaras S; Maniati M; Petinaki E; Tzouvelekis LS; Tsakris A; Legakis NJ; Maniatis AN
    J Antimicrob Chemother; 2003 Jun; 51(6):1409-14. PubMed ID: 12716773
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genomic characterization of carbapenem-non-susceptible
    Teo JQ; Tang CY; Lim JC; Lee SJ; Tan SH; Koh TH; Sim JH; Tan TT; Kwa AL; Ong RT
    Emerg Microbes Infect; 2021 Dec; 10(1):1706-1716. PubMed ID: 34384341
    [No Abstract]   [Full Text] [Related]  

  • 60. Mutational and acquired carbapenem resistance mechanisms in multidrug resistant Pseudomonas aeruginosa clinical isolates from Recife, Brazil.
    Cavalcanti FL; Mirones CR; Paucar ER; Montes LÁ; Leal-Balbino TC; Morais MM; Martínez-Martínez L; Ocampo-Sosa AA
    Mem Inst Oswaldo Cruz; 2015 Dec; 110(8):1003-9. PubMed ID: 26676375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.